Royce & Associates LP Opiant Pharmaceuticals, Inc. Transaction History

Royce & Associates LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$7.48 - $9.54 $14,952 - $19,070	-1,999 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$8.64 - $11.87 $17,271 - $23,728	1,999 New	1,999 $18,000
Q1 2019 May 09, 2019	SELL	$13.02 - $15.94 $8,111 - $9,930	-623 Closed	0 $0
Q4 2018 Feb 11, 2019	BUY	$13.84 - $18.79 $8,622 - $11,706	623 New	623 $9,000
Q3 2018 Nov 13, 2018	SELL	$12.89 - $23.43 $5,555 - $10,098	-431 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$14.31 - $20.59 $3,548 - $5,106	248 Added 135.52%	431 $6,000
Q1 2018 May 14, 2018	BUY	$18.8 - $26.5 $1,974 - $2,782	105 Added 134.62%	183 $4,000
Q4 2017 Feb 09, 2018	BUY	$18.16 - $40.15 $1,416 - $3,131	78	78 $2,000

300

Ticker OPNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,164,150
Description
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overd...

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

Stay updated on Royce & Associates LP with notifications on news.